Company intelligence / Profile preview

MoonWork

South San Francisco, California, United Statesmoonwork.org ↗

Ownership: Private
Development stage: Other

Overview

Moonwalk Biosciences, founded by leaders in genomics and epigenetics, has raised $57 million to develop a novel class of precision epigenetic medicines. The company leverages advanced AI-driven discovery platforms to identify new therapeutic opportunities by reading and writing the cellular epigenome. As of mid–2025, all programs are preclinical with a focus on cardiometabolic diseases.

Therapeutic areas: GastroenterologyPulmonologyCardiovascularNephrology
Modalities: Epigenetic therapySmall moleculeGene therapy
Industry: Biotech

Beyond the preview

Go deeper on MoonWork.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MoonWork.

Explore the full profile